Recent data show that both nonselective and selective PDE inhibitors might be useful in ARDS caused by a severe infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) leading to COVID-19. The gene discussed is ALDH7A1; the disease is acute respiratory distress syndrome.